Compare MIDD & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIDD | KRYS |
|---|---|---|
| Founded | 1888 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.3B |
| IPO Year | N/A | 2017 |
| Metric | MIDD | KRYS |
|---|---|---|
| Price | $157.53 | $270.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 11 |
| Target Price | $167.88 | ★ $257.45 |
| AVG Volume (30 Days) | ★ 725.9K | 307.0K |
| Earning Date | 02-24-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 275.72 |
| EPS | N/A | ★ 6.66 |
| Revenue | ★ $3,880,498,000.00 | $373,164,000.00 |
| Revenue This Year | $1.39 | $36.36 |
| Revenue Next Year | $3.82 | $42.15 |
| P/E Ratio | ★ N/A | $40.40 |
| Revenue Growth | 0.28 | ★ 54.51 |
| 52 Week Low | $110.82 | $122.80 |
| 52 Week High | $182.73 | $295.98 |
| Indicator | MIDD | KRYS |
|---|---|---|
| Relative Strength Index (RSI) | 63.34 | 49.01 |
| Support Level | $145.22 | $258.34 |
| Resistance Level | $159.06 | $286.52 |
| Average True Range (ATR) | 3.98 | 10.37 |
| MACD | 0.32 | -3.06 |
| Stochastic Oscillator | 88.67 | 24.57 |
The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.